Gene · 5771
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The SYSCID map: a graphical and computational resource of molecular mechanisms across rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease. | Front Immunol | 2023 | 38022524 | PubTator, text mining | PubMed |
| Discovery of a selective TC-PTP degrader for cancer immunotherapy. | Chem Sci | 2023 | 38020389 | PubTator, text mining | PubMed |
| Lipid-anchored proteasomes control membrane protein homeostasis. | Sci Adv | 2023 | 38019907 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Potential Targets for Diagnosis and Treatment of Oral Lichen Planus: A Narrative Review. | Biomolecules | 2023 | 38002328 | PubTator, text mining | PubMed |
| Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives. | Clin Transl Med | 2023 | 37983927 | PubTator, text mining | PubMed |
| Natural Products-Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry. | Molecules | 2023 | 37959859 | PubTator, text mining | PubMed |
| Developments in Genetics: Better Management of Ovarian Cancer Patients. | Int J Mol Sci | 2023 | 37958970 | PubTator, text mining | PubMed |
| PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy. | BMC Cancer | 2023 | 37957639 | PubTator, text mining | PubMed |
| Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer. | Front Oncol | 2023 | 37941546 | PubTator, text mining | PubMed |
| Pan-cancer analysis revealing that PTPN2 is an indicator of risk stratification for acute myeloid leukemia. | Sci Rep | 2023 | 37884566 | PubTator, text mining | PubMed |
| Advancements in CRISPR screens for the development of cancer immunotherapy strategies. | Mol Ther Oncolytics | 2023 | 37876793 | PubTator, text mining | PubMed |
| Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota. | Cell Biosci | 2023 | 37875976 | PubTator, text mining | PubMed |
| Unconventional T cells in brain homeostasis, injury and neurodegeneration. | Front Immunol | 2023 | 37854609 | PubTator, text mining | PubMed |
| Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity. | Molecules | 2023 | 37836790 | PubTator, text mining | PubMed |
| Genotype Prevalence of Lactose Deficiency, Vitamin D Deficiency, and the Vitamin D Receptor in a Chilean Inflammatory Bowel Disease Cohort: Insights from an Observational Study. | Int J Mol Sci | 2023 | 37834314 | PubTator, text mining | PubMed |
| Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches. | Int J Mol Sci | 2023 | 37834153 | PubTator, text mining | PubMed |
| Association between HMGCR, CRP, and CETP gene polymorphisms and metabolic/inflammatory serum profile in healthy adolescents. | J Transl Med | 2023 | 37833739 | PubTator, text mining | PubMed |
| An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy. | Aging (Albany NY) | 2023 | 37812190 | PubTator, text mining | PubMed |
| High-expressed PTPN1 promotes tumor proliferation signature in human hepatocellular carcinoma. | Heliyon | 2023 | 37810052 | PubTator, text mining | PubMed |
| Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy. | Immunotargets Ther | 2023 | 37795196 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5771/papers?page=9